77 related articles for article (PubMed ID: 20398754)
1. Vitamin D and prostate cancer: the role of membrane initiated signaling pathways in prostate cancer progression.
Karlsson S; Olausson J; Lundh D; Sögård P; Mandal A; Holmström KO; Stahel A; Bengtsson J; Larsson D
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):413-6. PubMed ID: 20398754
[TBL] [Abstract][Full Text] [Related]
2. Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α,25(OH)(2)D(3).
Chen J; Doroudi M; Cheung J; Grozier AL; Schwartz Z; Boyan BD
Cell Signal; 2013 Dec; 25(12):2362-73. PubMed ID: 23896121
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
4. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
5. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
Barreto AM; Schwartz GG; Woodruff R; Cramer SD
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664
[TBL] [Abstract][Full Text] [Related]
6. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
Schwartz GG; Whitlatch LW; Chen TC; Lokeshwar BL; Holick MF
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):391-5. PubMed ID: 9610788
[TBL] [Abstract][Full Text] [Related]
7. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
9. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ
Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Pdia3-dependent 1α,25-dihydroxy vitamin D3 signaling in musculoskeletal cells.
Boyan BD; Chen J; Schwartz Z
Steroids; 2012 Aug; 77(10):892-6. PubMed ID: 22569272
[TBL] [Abstract][Full Text] [Related]
12. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
13. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
14. Membrane actions of 1α,25(OH)2D3 are mediated by Ca(2+)/calmodulin-dependent protein kinase II in bone and cartilage cells.
Doroudi M; Plaisance MC; Boyan BD; Schwartz Z
J Steroid Biochem Mol Biol; 2015 Jan; 145():65-74. PubMed ID: 25263660
[TBL] [Abstract][Full Text] [Related]
15. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM
Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790
[TBL] [Abstract][Full Text] [Related]
16. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system.
Baeke F; Korf H; Overbergh L; van Etten E; Verstuyf A; Gysemans C; Mathieu C
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):221-7. PubMed ID: 20302932
[TBL] [Abstract][Full Text] [Related]
17. VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)
Nowak JI; Olszewska AM; Wierzbicka JM; Gebert M; Bartoszewski R; Żmijewski MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201216
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.
Peehl DM; Skowronski RJ; Leung GK; Wong ST; Stamey TA; Feldman D
Cancer Res; 1994 Feb; 54(3):805-10. PubMed ID: 7508338
[TBL] [Abstract][Full Text] [Related]
19. Cellular responses to silencing of PDIA3 (protein disulphide-isomerase A3): Effects on proliferation, migration, and genes in control of active vitamin D.
Kermpatsou D; Olsson F; Wåhlén E; Söderberg O; Lennartsson J; Norlin M
J Steroid Biochem Mol Biol; 2024 Jun; 240():106497. PubMed ID: 38460707
[TBL] [Abstract][Full Text] [Related]
20. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
